Cost of allergy immunotherapy: sublingual vs subcutaneous administration
- 19 June 2012
- journal article
- research article
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 2 (6) , 460-464
Abstract
Background: Allergy immunotherapy is an effective way to manage the allergic patient and may be administered either through the subcutaneous route (SCIT) or the sublingual route (SLIT). Both have been proven efficacious; however, SLIT is currently not covered by insurance companies and is an out‐of‐pocket expense. The goal of the current study is to compare the costs of SCIT to SLIT.Methods: For SCIT, a total of 9 different insurance groups were studied including 8 preferred provider organizations (PPOs) and Medicare. Costs were broken down according to the percentage of coverage for the injections, serum vial fees, weekly co‐pay, and deductibles. Total yearly cost for SCIT was calculated for the varying insurance plans and compared to the yearly cost of SLIT.Results: PPO plans covered between 60% and 100% of allergy immunotherapy treatment with a range of weekly co‐pay between $0 and $50. Deductibles ranged between $0 and $7000. Medicare had a flat rate of 80% coverage costing the insurer $807.20 for the year of therapy. None of the above costs include loss of work productivity and travel expense. The cost of SLIT ranged from $500 to $2100 depending on the allergy practice and number on antigens treated.Conclusion: The cost of SCIT varies dramatically according to insurance plan whereas the cost of SLIT varies between practices. When loss of productivity and travel expense are added into the cost of SCIT, SLIT might be comparable in cost and more convenient for the patient. Although the lack of insurance coverage for SLIT currently makes it more expensive than SCIT, we have found that the financial gap is much smaller than initially thought, especially when indirect costs and plans with less than 80% coverage or high weekly co‐pay are factored into the equation.Keywords
This publication has 9 references indexed in Scilit:
- Economic evaluation of sublingual vs subcutaneous allergen immunotherapyAnnals of Allergy, Asthma & Immunology, 2008
- Sublingual immunotherapy and allergic rhinitisCurrent Allergy and Asthma Reports, 2008
- Sublingual immunotherapy: The optimism and the issuesJournal of Allergy and Clinical Immunology, 2007
- Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) studyAnnals of Allergy, Asthma & Immunology, 2006
- Sublingual immunotherapy: A comprehensive reviewJournal of Allergy and Clinical Immunology, 2006
- Health-Economic Analyses of subcutaneous Specific Immunotherapy for grass pollen and mite allergyAllergologia et Immunopathologia, 2005
- Long‐lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10‐year prospective studyClinical & Experimental Allergy, 2003
- Economic Evaluation of Specific Immunotherapy Versus Symptomatic Treatment of Allergic Rhinitis in GermanyPharmacoEconomics, 2000
- Allergen Immunotherapy: Therapeutic Vaccines for Allergic DiseasesAnnals of Allergy, Asthma & Immunology, 1998